Your browser doesn't support javascript.
Will SARS-CoV-2 Become Just Another Seasonal Coronavirus?
Beams, Alexander B; Bateman, Rebecca; Adler, Frederick R.
  • Beams AB; Department of Mathematics, University of Utah, Salt Lake City, UT 84112, USA.
  • Bateman R; Division of Epidemiology, University of Utah, Salt Lake City, UT 84108, USA.
  • Adler FR; University of Utah, Salt Lake City, UT 84112, USA.
Viruses ; 13(5)2021 05 07.
Article in English | MEDLINE | ID: covidwho-1224256
ABSTRACT
The future prevalence and virulence of SARS-CoV-2 is uncertain. Some emerging pathogens become avirulent as populations approach herd immunity. Although not all viruses follow this path, the fact that the seasonal coronaviruses are benign gives some hope. We develop a general mathematical model to predict when the interplay among three factors, correlation of severity in consecutive infections, population heterogeneity in susceptibility due to age, and reduced severity due to partial immunity, will promote avirulence as SARS-CoV-2 becomes endemic. Each of these components has the potential to limit severe, high-shedding cases over time under the right circumstances, but in combination they can rapidly reduce the frequency of more severe and infectious manifestation of disease over a wide range of conditions. As more reinfections are captured in data over the next several years, these models will help to test if COVID-19 severity is beginning to attenuate in the ways our model predicts, and to predict the disease.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: V13050854

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: V13050854